Zobrazeno 1 - 10
of 490
pro vyhledávání: '"W, Reesink"'
Autor:
Vladimir V. Loukachov, Karel A. van Dort, Irma Maurer, R. Bart Takkenberg, Anniki de Niet, Henk W. Reesink, Sophie B. Willemse, Neeltje A. Kootstra
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
Background and AimsWith current standard of care a functional cure for Chronic Hepatitis B (CHB) is only achieved in 1-3% of patients and therefore novel therapies are needed. Disease activity during CHB can be determined by a broad range of virologi
Externí odkaz:
https://doaj.org/article/7d1b1f66e52d4143b82e49dffa1fa3d9
Autor:
Robin Erken, Hans L. Zaaijer, Sophie B. Willemse, Ed Bakker, Bart B. Takkenberg, Henk W. Reesink, Neeltje A. Kootstra
Publikováno v:
Annals of Hepatology, Vol 26, Iss , Pp 100540- (2021)
Introduction and Objectives: Covalently closed circular (ccc)DNA acts as a viral reservoir in the liver of patients with a chronic hepatitis B (CHB) infection and can only be quantified in liver biopsies. Hepatitis B core-related antigen (HBcrAg) lev
Externí odkaz:
https://doaj.org/article/4e448280b0504405aab18d7435ed65bd
Publikováno v:
Viruses, Vol 14, Iss 6, p 1223 (2022)
Hepatitis B Virus (HBV) encoded miRNAs were previously described and suggested to play a role in HBV replication and pathogenesis. In this study we aim to identify novel HBV encoded miRNAs in plasma and liver tissue samples from chronic hepatitis B (
Externí odkaz:
https://doaj.org/article/99637bd72eae4bd981d41767d465fe93
Autor:
Femke Stelma, Annikki de Niet, Marjan J. Sinnige, Karel A. van Dort, Klaas P. J. M. van Gisbergen, Joanne Verheij, Ester M. M. van Leeuwen, Neeltje A. Kootstra, Hendrik W. Reesink
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
Abstract Tissue resident memory T cells (TRM) have been identified in various tissues, however human liver TRM to date remain unidentified. TRM can be recognized by CD69 and/or CD103 expression and may play a role in the pathology of chronic hepatiti
Externí odkaz:
https://doaj.org/article/b56880598d574792ab00d0e87c2e8df7
Publikováno v:
Open Veterinary Journal, Vol 4, Iss 1, Pp 20-25 (2014)
It was the aim of the present study to test whey as protective protein for the sperm cell in the long-term boar semen preservation medium TRIXcell. Analyses of sperm cell motility using computer-assisted semen analysis (CASA) indicated that the whey
Externí odkaz:
https://doaj.org/article/50b1c4f03c3a4b5a82696e43137d0b70
Publikováno v:
Hepatology. John Wiley and Sons Ltd
Autor:
Vladimir V. Loukachov, Karel A. van Dort, Irma Maurer, R. Bart Takkenberg, Anniki de Niet, Henk W. Reesink, Sophie B. Willemse, Neeltje A. Kootstra
Publikováno v:
Frontiers in cellular and infection microbiology, 12:790964. Frontiers Media S.A.
Background and AimsWith current standard of care a functional cure for Chronic Hepatitis B (CHB) is only achieved in 1-3% of patients and therefore novel therapies are needed. Disease activity during CHB can be determined by a broad range of virologi
Autor:
Xun Qi, Adrian Streinu-Cercel, Heng Chi, Fehmi Tabak, Qing Xie, Mircea Diculescu, Margo J. H. van Campenhout, Elke Verhey, Harry L.A. Janssen, Willem P. Brouwer, Bettina E. Hansen, Hendrik W. Reesink, Włodzimierz Mazur, Rob J. de Knegt, Krzysztof Simon, Ningping Zhang, Meral Akdogan, J. Wang, S. Guo, Ramazan Idilman
Publikováno v:
Journal of viral hepatitis, 26(1), 109-117. Wiley-Blackwell
Journal of Viral Hepatitis, 26(1), 109-117. Wiley-Blackwell Publishing Ltd
Journal of Viral Hepatitis, 26(1), 109-117. Wiley-Blackwell Publishing Ltd
Addition of peginterferon alpha (PEG-IFN add-on) to entecavir (ETV) treatment after a short lead-in phase results in more response than ETV monotherapy in HBeAg-positive chronic hepatitis B infection (CHB). This study is the first to assess long-term
Autor:
Xiomara V Thomas, Joep de Bruijne, James C Sullivan, Tara L Kieffer, Cynthia K Y Ho, Sjoerd P Rebers, Michel de Vries, Hendrik W Reesink, Christine J Weegink, Richard Molenkamp, Janke Schinkel
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e41191 (2012)
BACKGROUND & AIMS: Telaprevir, a hepatitis C virus NS3/4A protease inhibitor has significantly improved sustained viral response rates when given in combination with pegylated interferon alfa-2a and ribavirin, compared with current standard of care i
Externí odkaz:
https://doaj.org/article/2e4b8e9596954b95a4c8867de164ece3
Deep sequencing identifies hepatitis B virus core protein signatures in chronic hepatitis B patients
Autor:
Matthijs R.A. Welkers, Meike H. van der Ree, Hendrik W. Reesink, K. Anton Feenstra, Louis Jansen, Neeltje A. Kootstra
Publikováno v:
Antiviral research, 158, 213-225. Elsevier
van der Ree, M H, Jansen, L, Welkers, M R A, Reesink, H W, Feenstra, K A & Kootstra, N A 2018, ' Deep sequencing identifies hepatitis B virus core protein signatures in chronic hepatitis B patients ', Antiviral research, vol. 158, pp. 213-225 . https://doi.org/10.1016/j.antiviral.2018.08.009
van der Ree, M H, Jansen, L, Welkers, M R A, Reesink, H W, Feenstra, K A & Kootstra, N A 2018, ' Deep sequencing identifies hepatitis B virus core protein signatures in chronic hepatitis B patients ', Antiviral research, vol. 158, pp. 213-225 . https://doi.org/10.1016/j.antiviral.2018.08.009
BACKGROUND: We aimed to identify HBc amino acid differences between subgroups of chronic hepatitis B (CHB) patients.METHODS: Deep sequencing of HBc was performed in samples of 89 CHB patients (42 HBeAg positive, 47 HBeAg negative). Amino acid types w